A prospective comparative study on neovascular glaucoma and non-neovascular refractory glaucoma following Ahmed glaucoma valve implantation

Zheng Li, Minwen Zhou, Wei Wang, Wenbin Huang, Shida Chen, Xingyi Li, Xinbo Gao, Zhang Xiu-lanChinese 2014 · DOI

Abstract

AGVI is a safe and effective procedure in refractory glaucoma, but the success rate of surgery was related to the type of refractory glaucoma. The complete and qualified success rates of NVG patient adjunctive anti-vascular endothelial growth factor treatment are still lower than those of non-NVG patients.
BibTeX
@inproceedings{li2014prospective,
  author = {Zheng Li and Minwen Zhou and Wei Wang and Wenbin Huang and Shida Chen and Xingyi Li and Xinbo Gao and Zhang Xiu-lan},
  title = {{A prospective comparative study on neovascular glaucoma and non-neovascular refractory glaucoma following Ahmed glaucoma valve implantation}},
  booktitle = {Chinese},
  year = {2014},
  doi = {10.3760/cma.j.issn.0366-6999.20132654},
}

Loading related content...

Figure